Interestingly, several reports using different cancer cell types, including GBM, have implicated hyperactive PI3K signaling and/or PTEN loss with an increase in PD-L1 expression at the cellular level (43, 44, 45, 46, 47). This evidence concerns the gene CD274 and glioblastoma.